The aim of this study was to examine the correlation between circulating levels of serum IGF-1, IGF-1R, AGEs, RAGE, and sRAGE and the risk of developing CRC in patients with T2DM. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.